bioRxiv Science⌕ Search

Biology subjects

Panchagnula, S. D. K.

Publications and source records attributed to Panchagnula, S. D. K..

2 recordsLinked to original sources

Computational Cellular Programming: In Silico Modeling of Direct and Reprogrammed Hepatic Lineage Induction via Gene Regulatory and Functional Dynamics

Understanding how cellular identity emerges from regulatory and energetic interactions remains a central question in developmental and synthetic biology. Here, we introduce a computational framework for in silico cellular programming, enabling the simulation of lineage acquisition through gene-regulatory and functional feedback dynamics. Two paradigms of hepatic identity induction were modeled: direct programming, representing immediate activation of hepatocyte master regulators from an undifferentiated baseline, and reprogramming, representing the conversion of a lineage-committed fibroblast into a hepatocyte-like state. Each simulation integrates a minimal hepatocyte gene regulatory network--comprising HNF4A, FOXA2, CEBPA, ALB, CYP3A4, and HNF1A--with condition-dependent feedbacks reflecting metabolic and morphological stability. Comparative analyses reveal that direct programming rapidly converges to a stable hepatic attractor with low variance and tight network coherence, whereas reprogrammed trajectories display delayed stabilization, higher variance, and context-dependent adaptability. These findings demonstrate that functional maturity can be algorithmically achieved through feedback-driven regulatory dynamics, and that morphological order predicts metabolic coherence. Together, they establish a conceptual foundation for computational cellular programming--where cell identity can be represented, manipulated, and matured as an emergent property of coded regulatory logic.

systems biology↗

Spatiotemporal Simulation of Radiotherapy Impact on Stage III Sigmoid Colon Cancer Using a Metabolically Coupled Agent-Based Model

Colorectal cancer (CRC), particularly sigmoid colon adenocarcinoma, presents complex therapeutic challenges at advanced stages. While fractionated radiotherapy combined with chemotherapy and immune involvement is clinically effective, its outcomes vary due to tumor heterogeneity, hypoxia, and treatment-induced resistance. This study develops a biologically grounded, lattice-based, agent-based model (ABM) of Stage III sigmoid colon cancer. The model simulates tumor cell proliferation, immune-tumor interactions, ATP-dependent metabolism, and oxygen diffusion via reaction-diffusion approximations. Tumor response to fractionated radiotherapy is governed by the Linear-Quadratic (LQ) model, with chemotherapy modeled as a radiosensitizer. Immune dynamics are represented both spatially and through a coupled ODE system. Simulations reveal progressive tumor volume reduction across radiotherapy fractions, emergence of resistant subclones in hypoxic zones, and variable immune infiltration based on comorbid factors. ATP levels regulate proliferation thresholds, while TCP/NTCP curves demonstrate dose-response windows. Survival fractions differ significantly between sensitive and resistant populations. This integrated ABM effectively captures the spatiotemporal evolution of CRC under radiotherapy and immune pressure. It provides a clinically meaningful platform to explore treatment outcomes, assess tumor control probabilities, and serve as a computational foundation for personalized therapy planning in colorectal cancer.

cancer biology↗